Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00232-3/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz--stl1UWkKUfi08lLC1RSa5wh-Wik4TWKlycVldU1uIqQv5_ajam1iPLZcFs7bHmaSdwGKUk9-t0LJewcMhDlN9L4fGNQ&utm_content=271743104&utm_source=hs_email